Clinical trial

Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing…

NCT00439283 · Association de Recherche Clinique en Rhumatologie, Other · Completed

Key facts

NCT number NCT00439283
Title Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis
Official title Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis: Comparison of Infusion Every 6 Weeks Versus Infusion on Demand
Lead sponsor Association de Recherche Clinique en Rhumatologie, Other
Status Completed
Phase Phase 3
Study type Interventional
Conditions Ankylosing Spondylitis
Intervention type Drug
Interventions infliximab, methotrexate
Enrollment 240
Start date Apr 1, 2003
Completion Dec 1, 2004
First posted Feb 23, 2007
Last update posted Feb 27, 2007
Countries France

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies